We are live on ! Find out more
FA

Fagan Associates Portfolio holdings

AUM $719M
1-Year Est. Return 26.65%
This Fund
S&P 500
This Quarter Est. Return
+1.4%
1 Year Est. Return
+26.65%
3 Year Est. Return
+87.69%
5 Year Est. Return
+107.31%
10 Year Est. Return
+467.14%
AUM
$156M
AUM Growth
+$4.81M
Cap. Flow
+$5.92M
Cap. Flow %
3.8%
Top 10 Hldgs %
34.74%
Holding
105
New
16
Increased
44
Reduced
31
Closed
10

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.39M
2
ABBV icon
AbbVie
ABBV
+$1.41M
3
T icon
AT&T
T
+$1.25M
4
BND icon
Vanguard Total Bond Market
BND
+$1.25M
5
HCA icon
HCA Healthcare
HCA
+$1.03M

Top Sells

Rank Stock Value
1
DAL icon
Delta Air Lines
DAL
+$1.52M
2
DHI icon
D.R. Horton
DHI
+$1.43M
3
AAPL icon
Apple
AAPL
+$1.25M
4
TIP icon
iShares TIPS Bond ETF
TIP
+$1M
5
CONE
CyrusOne Inc Common Stock
CONE
+$958K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.52%
2 Communication Services 12.91%
3 Financials 12.32%
4 Healthcare 10.94%
5 Technology 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DD icon
26
DuPont de Nemours
DD
$18.6B
$2.14M 1.38%
17,017
+1,634
+11% +$215K
DIS icon
27
Walt Disney
DIS
$165B
$2.13M 1.37%
21,791
-1,185
-5% -$119K
SVC
28
Service Properties Trust
SVC
$1.1B
$2.02M 1.3%
14,040
+744
+6% +$98.1K
RTX icon
29
RTX Corp
RTX
$287B
$1.91M 1.23%
29,654
+774
+3% +$49.5K
HAIN icon
30
Hain Celestial
HAIN
$47.8M
$1.86M 1.2%
37,475
+350
+0.9% +$16.2K
XOM icon
31
ExxonMobil
XOM
$651B
$1.83M 1.18%
19,517
-1,418
-7% -$125K
YUM icon
32
Yum! Brands
YUM
$41B
$1.73M 1.11%
28,933
+920
+3% +$54.2K
SCHD icon
33
Schwab US Dividend Equity ETF
SCHD
$102B
$1.68M 1.08%
121,560
+16,404
+16% +$221K
CRM icon
34
Salesforce
CRM
$134B
$1.63M 1.04%
20,460
-435
-2% -$34.1K
SPY icon
35
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$1.48M 0.95%
7,061
-84
-1% -$17.4K
ABBV icon
36
AbbVie
ABBV
$458B
$1.44M 0.92%
+23,178
New +$1.41M
T icon
37
AT&T
T
$165B
$1.38M 0.88%
+42,134
New +$1.25M
AMZN icon
38
Amazon
AMZN
$2.5T
$1.32M 0.85%
36,780
+1,600
+5% +$54.1K
XYL icon
39
Xylem
XYL
$28.5B
$1.3M 0.84%
29,130
+9,885
+51% +$430K
MCD icon
40
McDonald's
MCD
$188B
$1.2M 0.77%
10,009
-666
-6% -$83.4K
CVS icon
41
CVS Health
CVS
$137B
$1.17M 0.75%
12,246
+15
+0.1% +$1.5K
NVDA icon
42
NVIDIA
NVDA
$5.01T
$1.08M 0.7%
921,000
+100,000
+12% +$103K
SKT icon
43
Tanger
SKT
$4.82B
$1.06M 0.68%
26,294
-268
-1% -$9.76K
MDT icon
44
Medtronic
MDT
$107B
$1.05M 0.68%
+12,120
New +$980K
DEO icon
45
Diageo
DEO
$46.2B
$1M 0.65%
8,900
-50
-0.6% -$5.41K
HCA icon
46
HCA Healthcare
HCA
$84.8B
$1M 0.65%
+13,035
New +$1.03M
MMM icon
47
3M
MMM
$89B
$938K 0.6%
6,406
+19
+0.3% +$2.68K
BP icon
48
BP
BP
$113B
$913K 0.59%
30,556
-238
-0.8% -$6.41K
SCHA icon
49
Schwab U.S Small- Cap ETF
SCHA
$22.5B
$882K 0.57%
65,280
+864
+1% +$11.5K
SCHH icon
50
Schwab US REIT ETF
SCHH
$11.7B
$866K 0.56%
39,888
-818
-2% -$16.9K
1
2
3 4 5

Similar funds

EI
Ellevest Inc New York $719M AUM 23.17% 1-Year Est. Return
SAM
Summit Asset Management Memphis, Tennessee $719M AUM 13.76% 1-Year Est. Return
KC
Kadensa Capital Central, Hong Kong $718M AUM 38.33% 1-Year Est. Return
TFA
Tobias Financial Advisors Plantation, Florida $718M AUM 15.66% 1-Year Est. Return
WRPWM
Werba Rubin Papier Wealth Management San Jose, California $718M AUM 19.97% 1-Year Est. Return
WLIM
White Lighthouse Investment Management Bedford, Massachusetts $721M AUM 16.12% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
CFO
Cambient Family Office Ada, Michigan $716M AUM

Fagan Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Fagan Associates held 105 positions worth $156M, up 3.2% from $151M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Fagan Associates deployed $5.92M of net new capital in Q2 2016, opening 16 new positions and adding to 44 existing holdings. Its largest new stake was Gilead Sciences: 38,165 shares worth $3.18M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, down from 17% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was D.R. Horton, an estimated $1.43M trimmed.

  • Fagan Associates's largest Q2 2016 buy was Gilead Sciences: 38,165 shares worth $3.18M.
  • Fagan Associates added most to Vanguard Total Bond Market in Q2 2016, an estimated $1.25M increase.
  • Fagan Associates's biggest Q2 2016 reduction was D.R. Horton, cutting an estimated $1.43M.
  • Fagan Associates fully exited Delta Air Lines in Q2 2016, selling an estimated $1.52M.
  • Fagan Associates's ten largest holdings make up 35% of its $156M portfolio in Q2 2016.
  • Fagan Associates opened 16 new positions and closed 10 in Q2 2016.
  • Fagan Associates's portfolio value rose 3.2% quarter-over-quarter to $156M.

Based on Fagan Associates's 13F filing for Q2 2016, filed 5 Aug 2016.